Radiotherapy for Prostate Cancer: Study Says MRI Guidance Significantly Reduces GU and GI Toxicities
For patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer, the acute genitourinary (GU) toxicity rate associated with the procedure was 19 percent lower with magnetic resonance imaging (MRI) guidance in comparison to computed tomography (CT) guidance, according to new research presented recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Could an Emerging PSMA/PET Imaging Agent Improve the Detection of Recurrent Prostate Cancer?
In a recent video interview from the American Society for Radiation Oncology (ASTRO) Annual Meeting, Benjamin Lowentritt, MD discussed the challenges of conventional imaging in diagnosing prostate cancer recurrence and the potential of an emerging high affinity, radiohybrid prostate-specific membrane antigen/positron emission tomography (PSMA/PET) imaging agent.
Study Suggests Shorter Duration of Radiation Therapy is Effective for High-Risk Prostate Cancer
Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Can Increased Post-Op Surveillance Chest CT Have an Impact for Colorectal Cancer Patients?
Out of 1,600 patients who had surgery for colorectal cancer, nearly 15 percent had pulmonary metastases within 15.4 months and higher-risk patients experienced lung metastases within three months, according to new research presented at the Scientific Forum of the American College of Surgeons Clinical Congress.
In a recent video interview, interventional radiologist Lindsay Machan, MD, discussed his longtime work with selective salpingography and fallopian tube recanalization to assist women with infertility issues, and key findings from a new study that he recently presented at the Society of Interventional Radiology (SIR) conference.
Siemens Healthineers Get FDA Nod for New SPECT/CT Scanner
The newly FDA-cleared Symbia Pro.specta SPECT/CT Scanner, which reportedly offers a variety of enhanced capabilities including low-dose CT up to 64 slices and intuitive workflow guides, was launched at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.
In what may be the first study to examine clinical and polysomnographic aspects of obstructive sleep apnea (OSA) and coronary microvascular disease (CMD), researchers said the frequency of OSA may be a significant factor in the development of heart disease and related complications.
Detecting Intracranial Hemorrhages: Can an Emerging AI Advance Have an Impact?
A 3D whole brain convolutional neural network could provide enhanced sensitivity and specificity for diagnosing intracranial hemorrhages on computed tomography, according to new research presented at the Society for Imaging Informatics in Medicine (SIIM) conference in Kissimmee, Fla.
Emerging Radiology Research May Shed Light on Blocked Fallopian Tubes
Selective salpingography may provide enhanced assessment of fallopian tubes and fallopian tube recanalization could be a viable alternative to facilitate natural conception, according to new research from the Department of Radiology at the University of British Columbia.